in hypromellose capsules
Sponsors
Mikrobiomik Healthcare Company S.L.
Conditions
non-alcoholic steatohepatitis
Phase 2
Randomized, double-blind and multicentric study to assess the efficiency, security and tolerability of the faecal microbiota transfer in capsule form vs. placebo for the treatment of patients with non-alcoholic steatohepatitis (EMOTION)
WithdrawnCTIS2022-500185-94-00
Target: 96Updated: 2024-03-14
Randomized, double-blind and multicentric study to assess the efficiency, security and tolerability of the faecal microbiota transfer in capsule form vs. placebo for the treatment of patients with non-alcoholic steatohepatitis (EMOTION)
Not yet recruitingCTIS2022-500185-94-01
Target: 1Updated: 2025-02-17